Amin Sabet to Humans
This is a "connection" page, showing publications Amin Sabet has written about Humans.
Connection Strength
0.074
-
Sabet A. A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. N Engl J Med. 2024 May 02; 390(17):1632.
Score: 0.035
-
Sabet A, Pallotta JA. Dichotomous responses to thyroid hormone treatment in a patient with primary hypothyroidism and thyroid hormone resistance. Thyroid. 2011 May; 21(5):559-61.
Score: 0.014
-
Sabet A, Kim M. Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am. 2010 Apr; 43(2):329-51, viii-ix.
Score: 0.013
-
De Filippis EA, Sabet A, Sun MR, Garber JR. Pemberton's sign: explained nearly 70 years later. J Clin Endocrinol Metab. 2014 Jun; 99(6):1949-54.
Score: 0.004
-
He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA, Radovick S, Wondisford FE. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell. 2009 May 15; 137(4):635-46.
Score: 0.003
-
Machado DS, Sabet A, Santiago LA, Sidhaye AR, Chiamolera MI, Ortiga-Carvalho TM, Wondisford FE. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci U S A. 2009 Jun 09; 106(23):9441-6.
Score: 0.003